PCRX

MKT CAP:$903M

Pacira BioSciences, Inc.

Market Cap

$903M

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NASDAQ

Healthcare·Drug·🇺🇸·NASDAQ

Stock Price

$22.75-$1.71 (-6.99%)

Jun 5, 2026

52W High $27.2252W Low $19.16

Company Details

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL...

CEO

—

IPO Date

Feb 3, 2011

Website

www.pacira.com

Key Metrics TTM

Revenue

$735M

+4.6% YoY

Net Income

$5M

EPS (Diluted)

Free Cash Flow

$133M

Revenue / Share

$17.96

Gross Margin

79.3%

Operating Margin

3.1%

Net Margin

0.7%

FCF Margin

18.1%

P/S

1.2x

P/E

175.8x

Earnings Reports

Q2 2026

Aug 4, 2026

PENDING

Q1 2026

Apr 30, 2026

$177M+5.0%

FY 2025

Feb 26, 2026

$726M+3.6%

Q4 2025

Feb 26, 2026

$197M+5.1%

Q3 2025

Nov 6, 2025

$180M+6.5%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee